Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain
- PMID: 33180914
- PMCID: PMC7717181
- DOI: 10.1093/cid/ciaa1721
Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Children and Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain
Abstract
Background: Susceptibility of children and adults to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and persistence of antibody response to the virus after infection resolution remain poorly understood, despite their significant public health implications.
Methods: A prospective cross-sectional seroprevalence study with volunteer families that included at least 1 first-reported adult case positive by SARS-CoV-2 by polymerase chain reaction (PCR) and at least 1 child aged <15 years living in the same household under strict home confinement was conducted in the metropolitan Barcelona Health Region, Spain, during the pandemic period 28 April 2020-3 June 2020. All household members were tested at home using a rapid SARS-CoV-2 antibody assay with finger prick-obtained capillary blood.
Results: A total of 381 family households including 381 first-reported PCR-positive adult cases and 1084 contacts (672 children, 412 adults) were enrolled. SARS-CoV-2 seroprevalence rates were 17.6% (118 of 672) in children and 18.7% (77 of 335) in adult contacts (P = .64). Among first-reported cases, seropositivity rates varied from 84.0% in adults previously hospitalized and tested within 6 weeks since the first positive PCR result to 31.5% in those not hospitalized and tested after that lag time (P < .001). Nearly all (99.9%) positive children were asymptomatic or had mild symptoms.
Conclusions: Children appear to have similar probability as adults to become infected by SARS-CoV-2 in quarantined family households but remain largely asymptomatic. Adult antibody protection against SARS-CoV-2 seems to be weak beyond 6 weeks post-infection confirmation, especially in cases that have experienced mild disease.
Keywords: COVID-19; SARS-CoV-2; antibody; household; prevalence.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures
References
-
- World Health Organization. Novel coronavirus—China. Available at: http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed 31 July 2020.
-
- Centro de Coordinación de Alertas y Emergencias Sanitarias. Actualización n. 219. Enfermedad por el coronavirus (COVID-19). 01.10.2020. Available at: https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasAct.... Accessed 1 October 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
